HIGHLIGHTS
- who: Thromboembolism et al. from the of ETNA-AF-Europe from and the NetherlandsCentres/University of Amsterdam, Amsterdam, The have published the article: Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study, in the Journal: (JOURNAL) of 24/Oct/2016
- what: With data from the largest phase IV study on edoxaban users with AF to date, we observed several important differences regarding patient characteristics and dose selections between BeNe and OEC.
- future: More studies on regional differences are needed to determine whether . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.